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Ltd. This is an open access article unAbstract Objective: Toassess thenormal levels ofnasal nitricoxide (NNO)and fractional exhaled
nitric oxide (FENO) in healthy Chinese young people, and to determinewhether the obtained values
were associated with age, sex, height, weight, BMI (body mass index) or BSA (body surface area).
Methods: One hundred and twenty healthy people were selected from a total of 436 Chinese young
people based on their answers to a questionnaire. An electrochemical analyzer (NIOXMINO system)
was used to measure NNO and FENO. The relationship between NNO, FENO and age, sex, height,
weight, BMI, BSA was analyzed using SPSS software.
Results: The values ofNNOwerenormal distributed (mean 273.5ppb; SD112.3). The values of FENO
werenon-normally (Skewed)distributed (median:14.00ppb; interquartile range:7.00ppb).Theob-
tained NNO values were independent of age, sex, height, weight, BMI and BSA, but were positively
correlated to lnFENO (FENO log base e); lnFENO values were also independent of age, height,
weight, BMI and BSA, but correlated with NNO and sex.
Conclusions: NNO values positively correlate with lnFENO in healthy people and the levels of each
may be predicted by the other. The results of this study are expected to serve as a reference for
future studies in China.
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Normal values of nasal NO and exhaled NO 23IntroductionSince the discovery of its function as an endothelium-
derived relaxing factor in 1987, nitric oxide (NO) has been
further documented to be present in the exhaled air of
rabbits, guinea pigs, and humans.1 Nasal nitric oxide (NNO)
refers to NO measured in air aspirated from the nasal
cavity. The main source of this gaseous molecule is the
paranasal sinus epithelium. The physiological role of NNO is
to modulate ciliary motility, and to serve as an aerocrine
mediator that helps to maintain adequate ventilation
perfusion matching in the lung and nasal cavity. NO can kill
bacteria, viruses, fungi, and tumor cells at high concen-
trations. In addition, inflammatory factors can activate
nitric oxide synthetase (NOS), which can lead to a rapid
increase in NNO concentration. NNO was recommended in
Europe as the preferred first-line test for Primary Ciliary
Dyskinesia (PCD) prior to performing confirmatory diag-
nostic tests in 2009.2 Patients with severe nasal polyps have
low levels of NNO, which increase markedly following
therapy.3 In patients with allergic rhinitis, NNO levels tend
to be high and decrease following treatment.4 High levels
of NNO almost certainly rule out the presence of cystic
fibrosis.5 FENO refers to NO measured in air exhaled from
the lower airway. FENO is produced by the human lung and
is present in exhaled breath. The measurement of FENO has
been standardized for clinical use and has been implicated
in the pathophysiology of lung diseases, including asthma.6
NO is usually measured by chemiluminescence or electro-
chemical analyzers, which are secure, non-invasive,
repeatable, and feasible methods. The development of
sensitive techniques for the instantaneous measurement
and monitoring of NO concentrations in human airways has
spurred many clinical studies focused on monitoring dis-
eases and the effects of treatments.
Although some progress has been made, the use of NNO
as a marker of upper airway diseases within clinical prac-
tice still needs to be developed. In contrast to FENO, there
is no current consensus on the normal values of NNO. In
China, there have only been two reports about normal NNO
levels; however, they reported different and inconsistent
results.7,8 Therefore, in this study, we aimed to assess the
normal values of NNO and FENO in healthy young people in
China, and to determine the factors that affect NNO and
FENO levels.
Materials and methods
Subjects
In total, 436 Chinese young people (aged 9e22 years)
recruited from one college and one middle school were
invited to participate in this study. The inclusion criteria
were: aged between 9 and 22 years and written consent
from themselves or their parents. The subjects were first
asked if they had experienced any nasal or lower respira-
tory symptoms, including itching, rhinorrhea, sneezing,
obstruction, cough, wheezing, and asthma, in the last four
weeks. Subjects experiencing any nasal or lower respiratory
symptoms were excluded. The remaining subjects werethen asked to fill out an extensive questionnaire, which
included potential confounding factors (sex, age, height,
weight, BMI, BSA) and the exclusion criteria: history of
respiratory diseases including rhinitis, deviation of nasal
septum, nasal polyps, sinusitis, asthma, cough, wheezing,
chronic pharyngitis, systemic or nasal administration of
medications within two weeks; consumption of caffeine-
containing beverages such as coffee, tea or colas; con-
sumption of foods rich in nitrogen such as sausage, various
animal offal, lettuce, and spinach within 2 h; respiratory
tract infection within two weeks; related history of nasal
operation; physical exercise within two hours of NO mea-
surement; active or passive smoking.
The Ethical Committee of the Chinese People’s Libera-
tion Army General Hospital (Beijing, China) approved the
study protocol.Methods
NNO and FENO measurements
NNO and FENO were measured online according to the NIOX
MINO manual (Aerocrine AB, Solna, Sweden). NIOX MINO
does require ambient NO measurement. The NO measure-
ment unit was parts per billion (ppb). The NNO measure-
ment range was 5e1700 ppb, and the FENO measurement
range was 5e300 ppb. The machine automatically recorded
and stored the FENO and NNO values.
The measurement of NNO: The subjects rested for at
least 30 min before measurement. A NO-inert olive tip was
blocked firmly against the right nostril and was connected
to NIOX MINO through a sampling tube. The flow rate was
5 ml/s. Subjects were asked to breathe normally and then
hold their breath for 45 s. The concentration of NNO was
automatically calculated by the NIOX MINO system.
The measurement of FENO: The subjects rested for
15 min after NNO measurement. The subjects were then
asked to stand and exhale to residual volume. A mouth-
piece was then inserted, the patient inhaled to total lung
capacity and then exhaled for 10 s at a constant flow rate of
about 50 ml/s. The NIOX MINO automatically reported the
detected FENO concentrations.Statistical analysis
All data were entered into a computer twice by two in-
dividuals. A one-Sample KolmogoroveSmirnov Test was
performed to analyze the distribution of baseline vari-
ables, which were described as the mean  standard de-
viation (SD). FENO values and age were non-normally
distributed, and they were expressed as the median
(interquartile range, IQR). Logarithmic transformations
were performed for FENO values and expressed as lnFENO.
Correlation was examined using the Pearson and
Spearman correlation analysis, and linear regression
analysis was used to derive the prediction rules for NNO
and FENO values. A P < 0.05 was considered statistically
significant. All statistical procedures were performed
using SPSS software, version 13.0.
Table 1 General characteristics of subjects and NNO/
FENO levels (n Z 120).
Minimum Maximum Mean  SD or
median (IQR)
Distribution
NNO (ppb) 16 582 273.50
 112.28
Normal
FENO (ppb) 5 73 14.0 (7.0) Non-Normal
Age (year) 9 22 15.0 (5.0) Non-Normal
Height (cm) 133.400 191.00 163.05  10.76 Normal
Weight (kg) 30.00 82.00 51.88  10.94 Normal
BMI (kg/m2) 12.527 27.042 19.37  2.77 Normal
BSA (m2) 1.08 2.007 1.64  0.19 Normal
IQR, interquartile range; SD, standard deviation; BMI, body
mass index; BSA, body surface area.
Table 2 Correlations among lnFENO, NNO, and other
factors.
NNO lnFENO
r P R P
Sex 0.094 0.307 0.248 0.006a
Age 0.025 0.789 0.081 0.377
Height 0.051 0.577 0.144 0.117
Weight 0.045 0.622 0.123 0.181
BMI 0.091 0.323 0.042 0.646
BSA 0.020 0.828 0.147 0.110
lnFENO 0.283 0.002a / /
NNO / / 0.283 0.002a
lnFENO, FENO log base e; SD, standard deviation; BMI, body
mass index; BSA, body surface area; r, correlation coefficient.
a Correlation is significant at the 0.01 level (2-tailed).
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In total, 436 Chinese young people (aged 8e22 years) were
willing to participate in this study, including 200 males
(45.9%) and 236 females (54.1%). Of these volunteers, 279
were excluded due to nasal or lower respiratory symptoms.
An additional 37 people were excluded after the second,
more detailed, questionnaire. In total, 120 (27.5%) subjects
(aged 9e22, average age 15.1 years) satisfied our re-
quirements, and were selected to undergo NNO and the
FENO measurement (Fig. 1). Of these subjects, 49 were
male (40.8%) and 71 were female (59.2%). The general
characteristics of the participants and their NNO and FENO
results are displayed in Table 1.
NNO values
NNO values were normally distributed [(273.50  112.28)
ppb, 95% CI, 253.20e293.80 ppb] with a 95% reference
value range (prediction interval) of 53.43e493.57 ppb, and
an absolute range from 16 to 582 ppb. Correlation analysis
revealed that the NNO values were independent of age,
sex, height, weight, BMI and BSA, but correlated positively
with lnFENO (rZ 0.283, P Z 0.002), Table 2.
FENO values
The FENO values were not normally distributed. The me-
dian FENO value was 14.00 ppb (IQR, 7.00 ppb). The
maximum was 73 ppb and the minimum 5 ppb with a 95%
reference value range of 5.93e35.87 ppb. After logarithmic
base e transformations of the FENO values, the resulting
lnFENO values were normally distributed. Correlation ana-
lyses revealed that lnFENO values were independent of age,
height, weight, BMI, and BSA. However lnFENO values were
correlated positively with NNO and sex (male Z 2,
female Z 1, r Z 0.248, P Z 0.006). A prediction rule for
lnFENO and FENO values in healthy patients can be derived
from NNO measurements:
lnFENOZ 2.084þ 0.001063650672482 NNO
þ 0.2150389683607 sex.
FENO Z e2.084 þ 0.001063650672482  NNOþ0.2150389683607  sex.Succeﬀully
 measured
120
Invited 
436 
Included 157 
without nasal 
symptoms 
Excluded 279 
with nasal 
symptoms  
Excluded by quesƟonnaire
37
Enrolld 
120 
Fig. 1 Flow chart of the study.For example, if a girl’s NNO is 300 ppb, then the pre-
dicted FENO concentration would be 13.71 ppb
(Ze2.084 þ 0.001063650672482  300 þ 0.2150389683607  1). NNO can
also be predicted from FENO values as follows: NNO Z
141.426 þ 355.594  lnFENO  113.267  lnFENO2 þ
14.254  lnFENO3. For example, if FENO Z 20 ppb and
lnFENO Z 3, then the approximate NNO concentration
would be 290.811 ppb (Z141.426 þ 355.594 
3e113.267  32 þ 14.254  33).Discussion
The official ATS (American Thoracic Society) clinical prac-
tice guidelines for the interpretation of FENO levels for
clinical applications was issued in 2012.6 However, stan-
dardization of measurements, the establishment of refer-
ence values, and reference equations for NNO have not yet
been developed. The measurement of NNO as a non-
invasive method will be of great value in the field of rhi-
nology. Since its first description in 1993, more studies have
focused on FENO rather than NNO. The few studies
reporting NNO values were variable and do not agree with
one another (Table 3). In China specifically, only two
Normal values of nasal NO and exhaled NO 25reports have measured NNO levels, and their results were
not in agreement.7,8 NNO levels are more susceptible than
FENO to factors such as season,9 time of day,10 and the
analyzer used,1 and NNO has a high degree of inter-
individual variability among healthy people. For these
reasons, NNO seems to be used less frequently than FENO in
clinical settings. However, most researchers agree that
extremely low levels of NNO can predict PCD or cystic
fibrosis.2,5,11e13 In addition, NNO varies between individuals
over time, meaning that 20%e25% of the normal variation
seen is not reflective of changes in disease status or
response to medication. Therefore, in the same patient,
NNO values can change more than 25% without the influ-
ence of medications or disease status.14
The healthy subjects measured in our study were strictly
selected based on ATS/ERS (European Respiratory Society)
recommendations. A strict screening of all 436 subjects
through questionnaire survey identified those with poten-
tially confounding factors including food, drink, medica-
tion, smoking, sports, respiratory diseases, and surgery. InTable 3 Reported NNO levels in healthy people and association
Year First author Healthy people NNO levels in ppb
2002 Colantonio D19 n Z 20 740.9  148.1
2002 Narang I20 n Z 53 716
2003 Wodehouse T12 n Z 16 759  145.8
2005 Struben VM16 n Z 340 449  115
2007 Stark H9 n Z 18 Winter 133.5  29.
n Z 17 Summer 138.0  4
n Z 21 Autumn 121.0  37
2008 Dressel H10 n Z 19 7 AMe9 AM: 1505 
11 AMe1 PM: 1736
1 PMe3 PM: 1730 
3 PMe5 PM: 1740 
5 PMe7PM: 1670 
11 AMe1 PM: 1736
2009 Zhang L7 n Z 80 819  211
2010 Williamson PA15 n Z 41 878.1 (807.0e955.6
2010 Kramer MF21 n Z 11 1380 (988e2097)
2010 Piacentini GL17 n Z 43
(cooperative)
396.9  25.0
2011 Zhou H22 n Z 35 303  90
2011 Marthin JK13 n Z 52 534  30
2012 Leng YG8 n Z 182 79  35
2012 Lee KJ23 n Z 34 276  88
2012 Irander K24 n Z 7 79  33
2013 Marthin JK11 n Z 21 MINO5, TB (nVC): 3
n Z 21 MINO2, TB (nVC): 7
n Z 8 NIOX MINO5, BH (V
n Z 21 NIOX FLEX, TB (nV
n Z 21 CLD 88 sp, TB (nVC
n Z 21 NIOX FLEX, BH (VC
n Z 21 CLD 88 sp1(VC): 79
BMI, body mass index; BSA, body surface area; MINO5: sampling rat
breathing hold; nVC: on-velum closure; VC: velum closure; NIOX
Nasal(hand-hold), NIOX FLEX(stationary); CLD 88 sp and CLD 88 sp1 (Eaddition, subjects with nasal or respiratory symptoms
including itching, rhinorrhea, sneezing, obstruction, cough,
wheezing, and asthma were also excluded. Finally, 120
healthy young students that satisfied all requirements were
enrolled and successfully completed NNO and FENO mea-
surement. Standard operating procedures (SOP) for NIOX
MINO were used to measure NNO and FENO levels in order
to guarantee that our results were objective and reliable.
General subject characteristics including age, sex,
height, weight, BMI, and BSA may affect NNO and FENO
levels (Tables 3 and 4). We found that NNO values were
independent of age, sex, height, weight, BMI, and BSA, but
correlated positively with lnFENO. The correlation between
NNO and lnFENO (FENO) means that one value may be
calculated from the other, which has not been previously
reported, and may be helpful in the diagnosis and treat-
ment of respiratory system diseases. Williamson PA et al15
found that NNO and FENO were correlated in healthy vol-
unteers (rZ 0.44, PZ 0.004), which is consistent with the
results of our study. Multiple linear regressions of the wholewith other factors.
NNO associated
With age (<12 yrs), but not sex,
passive smoking, or BMI
7
7.6
.5
113
 109
105
95
103
 109
With age and gender,
but not height or BMI
) ppb Without age, sex
With age and weight, but
not gender, height, or BMI
No relationship with age, gender,
height, BMI, measure time, or right-left side
40  23
52  59
C): 603  42
C): 486  34
): 499  35
): 890  62
9  57
e 5 ml/s; MINO2: sampling rate 2 ml/s; TB: tidal breathing; BH:
(Aerocrine AB, Solna, Sweden): NIOX (hand-hold), NIOX MINO
CO MEDICSH AG, Duernten, Switzerland).
Table 4 Reported FENO levels in healthy people and their association with other factors.
Year First author Healthy people number
and years
FENO levels in ppb mean
 SD or mean (range)
FENO associated
2005 Wong GK25 n Z 258(Chinese)
(14.0  1.6) yrs
Male: 10.8 (7.8e17.6)
Female: 9.1 (7.5e11.9)
With gender, but not age, height,
weight, BMI, or BSA
2006 Malmberg LP26 n Z 114
11.3 (7.2e15.7) yrs
10.3 With age, height, weight, and BSA,
but not gender
2008 Kovesi T27 n Z 657
(10.8  0.89) yrs
14.0  13.4 Not with age, gender, or BMI
2008 Herva´s D28 n Z 15
9.5 (6e16) yrs
7.9 (5.9e10.6) With gender and age
2009 Banovcin P29 n Z 27
(12  4) yrs
12.4  1.2 With gender and age.
2010 Matsunaga K30 n Z 240
(18e74) yrs
16.9 (6.5e35.0) Not with age, gender, or height
2012 Janahi L31 n Z 203
(12e18) yrs
14.7 (5.0e90.5) Negatively associated with age and gender
BUT height, weight, BMI
2013 Zhang H32 n Z 300
(6e14) yrs
Male:13, IQR 9e18
Female:10, IQR 8e14
With gender and age
BMI, body mass index; BSA, body surface area; IQR, interquartile range.
26 S. You et al.cohort demonstrated that after diagnosis, age, sex, and
inhaled corticosteroids were taken into account, NNO was
significantly associated with FENO (P Z 0.02). Zhang L
et al7 found that NNO values were associated with age and
gender, but not height or BMI. Leng G et al8 came to a
similar conclusion as that of the present study, namely that
NNO levels in healthy people were independent of age, sex,
height, weight, and BMI. However, Struben VM et al16 found
that NNO concentrations were not associated with sex,
passive smoking, or BMI, but that in children aged <12 yrs,
NNO correlated positively with age. Piacentini GL et al17
reported that age and NNO concentration were signifi-
cantly related in pre-school children and that children older
than 6 years had levels of NNO that were about 100 ppb
higher than those of children aged 3 or under. This can be
explained by the accelerated pneumatization of developing
paranasal sinuses that occurs during childhood. Similarly to
other studies,18 we also found significantly higher FENO
levels in males compared to females. The relationship be-
tween FENO and gender may be due to geometrical factors
such as the total airway mucosal surface area and the
airway caliber, both of which can affect FENO output.
Interestingly, in our study, FENO did not correlate with the
age, which is not consistent with the majority of previous
studies (Table 4). Age has been found to be a strong factor
that effects FENO concentration in children younger than
12 yrs. These inconsistent results may be explained by the
fact that the majority of subjects were aged >12 yrs in this
study, and that only 9.16% of subjects were aged <12 yrs.
Struben VM et al16 found that FENO correlated positively
with age in children aged <12 yrs, but not in children aged
>12 yrs, and that ambient NO was the only significant
modifier in older children. The different outcomes of the
various studies may be due to the following four possible
explanations. First, individual differences depend on the
sinus development, and sinus pneumatization is differs
between all individuals. Second, some experts have found
that the NNO levels of healthy subjects were lower in themorning than in the afternoon.9,10 Third, different equip-
ment and different sampling flow rates may yield different
results. Marthin JK et al11 found that using different in-
struments lead to different results. Measurements acquired
at a sampling rate of 5 ml/s were superior to those acquired
at 2 ml/s using the same instrument. Last, ambient NO
levels may influence NNO levels. Although our instrument is
unaffected by ambient NO, the instruments used in other
studies may have been affected by it. High concentrations
of ambient NO may reduce the gradient for NO diffusion
from the nasal epithelium to the nasal cavity. Struben VM
et al16 found that the level of ambient NO (5e182 ppb)
heavily influenced the measured levels of NNO in their
study.
In conclusion, NNO values were independent of age, sex,
height, weight, BMI, and BSA, but correlated positively with
lnFENO. FENO values were also independent of age, height,
weight, BMI and BSA. However, lnFENO values were corre-
lated positively with NNO and sex. Although the relation-
ship between NNO and lnFENO should be studied further,
we hope that the results of this study may be helpful in the
future clinical application of NNO.
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